Progesterone as a mediator of gonadotrophin action in the corpus luteum: beyond steroidogenesis.
Studies using newer, potent GnRH antagonists and pure gonadotrophins have clarified the importance of: (i) the strength-duration of the midcycle surge of pituitary gonadotrophins (LH, FSH) in follicle rupture and conversion to the corpus luteum; (ii) the continued requirement for pituitary LH throughout development and the functional lifespan of the primate corpus luteum in the menstrual cycle; and (iii) the exponential secretion of chorionic gonadotrophin (CG) by the developing placenta to extend the functional lifespan of the primate corpus luteum in early pregnancy. Although studies continue to increase current understanding of the cellular and molecular actions of LH/CG to stimulate luteal steroidogenesis, knowledge of the processes whereby these gonadotrophins promote the development and maintenance of the functional corpus luteum remains limited. This review summarizes evidence that the primate ovulatory follicle and corpus luteum is a target for the primary steroid produced by luteinizing/luteal tissue (i.e. progesterone). With evidence for dynamic expression of genomic progesterone receptors (PRA/B), and possibly other progesterone-receptor systems, recent studies addressed the hypothesis that progesterone is a critical 'local luteotrophin' that promotes luteal development and sustains luteal structure-function during the menstrual cycle and early pregnancy. Specific progesterone actions to regulate tissue remodelling (via protease expression), health (anti-apoptotic effects) and sensitivity to other local factors (e.g. via estrogen receptor expression) are discussed. The collective data suggest that there are gonadotrophin-stimulated, progesterone-dependent processes that promote luteotrophic and suppress luteolytic pathways in the primate corpus luteum. However, further studies are needed to verify their role in normal ovarian function and relevance to possible ovarian defects in natural and assisted reproduction technique-related cycles.
Stouffer
R L
RL
Division of Reproductive Sciences, Oregon National Primate Research Center/Oregon Health & Science University, Beaverton, Oregon 97006, USA. stouffri@ohsu.edu
D000818:Animals; D006063:Chorionic Gonadotropin / Q000502:physiology; D003338:Corpus Luteum / Q000502:physiology*; D010450:Endopeptidases / Q000502:physiology; D005260:Female; D005640:Follicle Stimulating Hormone / Q000502:physiology; D006062:Gonadotropins / Q000502:physiology*; D006801:Humans; D007986:Luteinizing Hormone / Q000502:physiology; D008597:Menstrual Cycle / Q000502:physiology; D006080:Ovarian Follicle / Q000166:cytology / Q000502:physiology; D010060:Ovulation / Q000502:physiology; D011247:Pregnancy; D011374:Progesterone / Q000502:physiology*; D011980:Receptors, Progesterone / Q000502:physiology; D013256:Steroids / Q000096:biosynthesis
D006063:Chorionic Gonadotropin; D006062:Gonadotropins; D011980:Receptors, Progesterone; D013256:Steroids; D011374:Progesterone; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D010450:Endopeptidases